

Apatinib Mesylate Tablets
JIANGSU HENGRUI MEDICINE CO.,LTD
Quick Info
This product is suitable for patients with advanced gastric adenocarcinoma or gastroesophageal junction adenocarcinoma who have progressed or relapsed after at least 2 systemic chemotherapy treatments. Patients should be in good general condition during treatment.
[Ingredients]
The main ingredient of this product is apatinib mesylate
Chemical name: N-[4-(1-cyanocyclopentyl) phenyl]-2-(4-pyridylmethyl)amino-3-pyridinecarboxamide methanesulfonate
Chemical structure:
Molecular formula: C24H23N5O·CH4SO3
[Indications] This product is suitable for patients with advanced gastric adenocarcinoma or gastroesophageal junction adenocarcinoma who have progressed or relapsed after at least 2 systemic chemotherapy treatments. Patients should be in good general condition during treatment.
Calculated as apatinib (C24H23N5O): (1) 0.425 g; (2) 0.375 g; (3) 0.25 g.
[Usage and Dosage] This product should be used under the guidance of an experienced doctor.
Recommended dose: 850 mg, once a day.
Dosage: Oral, half an hour after a meal (the time of daily medication should be as consistent as possible), with warm water. The dose of apatinib missed during the course of treatment cannot be supplemented. Treatment duration: Continuous use until disease progression or intolerable adverse reactions occur.
[Contraindications] This product should not be used by patients who are allergic to any of its ingredients; it should not be used by patients with active bleeding, ulcers, intestinal perforation, intestinal obstruction, within 30 days after major surgery, hypertension that cannot be controlled by drugs, grade III-IV heart failure (NYHA standard), and severe liver and kidney failure (grade 4).
Medicine

Etoposide Injection
Mainly used to treat small cell lung cancer, malignant lymphoma, malignant germ cell tumor, leukemia, neuroblastoma, rhabdomyosarcoma, ovarian cancer, non-small...
1-1.png)
Sintilimab Injection
Classical Hodgkin's lymphoma, Non-squamous non-small cell lung cancer, Squamous non-small cell lung cancer, Hepatocellular carcinoma, Esophageal squamous cell carcinoma, Gastric...

Apatinib Mesylate Tablets
This product is suitable for patients with advanced gastric adenocarcinoma or gastroesophageal junction adenocarcinoma who have progressed or relapsed after...

Anlotinib Hydrochloride Capsules
Anlotinib is a new small molecule tyrosine kinase inhibitor of multi-targets, which acts effectively on targets such as VEGFR, PDGFR,...
Related News

China’s innovative drugs gain momentum in global expansion efforts

Virtual mental health care visits: Making them work for youChinese-made new drugs big hit overseasVirtual mental health care visits: Making them work for you

Accelerating Chinese Innovative Drugs Going Global: International New Drug R&D Regulation Forum Successfully Held